Upgrade to SI Premium - Free Trial

Aptinyx (APTX)

0.06 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Apotex gets BBB (low) rating, revises credit deal with $1.2B facility July 16, 2026 3:30 PM - StreetInsider Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement July 16, 2026 3:30 PM - PR NewsWire Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection July 8, 2026 9:01 AM - PR NewsWire Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M July 1, 2026 9:02 AM - StreetInsider Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals July 1, 2026 9:01 AM - PR NewsWire Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex July 1, 2026 9:00 AM - PR NewsWire Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management June 30, 2026 4:20 PM - PR NewsWire Knoa Pharma Begins Operations as a New, Public Health-Focused Company Dedicated to Supporting Patients and Abating the Opioid Crisis May 1, 2026 1:15 PM - BizWire Full Article List